In an RMS model, where RD cells were orthotopically inoculated into mice (Figure 5A), i.v. weekly administration of EphA2‐CAR‐NK92 or fortnightly pNK cells significantly suppressed local tumour progression (Figure 5B‒D). This evidence concerns the gene EPHA2 and neoplasm.